Anna Thiemann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Thiemann has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amit G. Singal
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
10 shared publications - Mandana Khalili
University of California, San Francisco
10 shared publications - Patricia D. Jones
Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, USA
10 shared publications - Paulo S. Pinheiro
Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA
10 shared publications - Ramsey Cheung
Gastroenterology and Hepatology The Palo Alto Veterans Affairs Health Care System Palo Alto California USA
10 shared publications - Rebecca G. Kim
Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Utah School of Medicine, Salt Lake City, Utah, USA
10 shared publications
Latest Publications
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 7 shows results from the adjusted multivariable competing risks analyses evaluating for predictors of HCC-specific mortality, stratified by race/ethnicity.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 7 shows results from the adjusted multivariable competing risks analyses evaluating for predictors of HCC-specific mortality, stratified by race/ethnicity.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 3 shows results from the adjusted multivariable logistic regression analyses evaluating for predictors of receiving HCC surgical treatment, stratified by race/ethnicity.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 3 shows results from the adjusted multivariable logistic regression analyses evaluating for predictors of receiving HCC surgical treatment, stratified by race/ethnicity.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Data from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Background:Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the United States.Methods:Using NCI registry data spanning 2000 to 2020, adults with HCC were evaluated to determine race/ethnicity-specific differences in tumor stage at diagnosis, delays and gaps in treatment, and survival. Adjusted regression models evaluated predictors of HCC outcomes.Results:Among 112,389 adults with HCC, cohort characteristics were as follows: 49.8% non-Hispanic White (NHW), 12.0% African American(AA), 20.5% Hispanic, 16.5% Asian/Pacific Islander, and 1.1% American Indian/Alaska Native. Compared with NHW patients, AA patients had lower odds of localized-stage HCC at diagnosis [adjusted odds ratio (aOR), 0.84], lower odds of HCC treatment receipt (aOR, 0.77), greater odds of treatment delays (aOR, 1.12), and significantly greater risk of death [adjusted hazards ratio (aHR), 1.10]. Compared with NHW patients from large metro areas, AA patients from large metro areas had 8% higher mortality risk (aHR, 1.08), whereas AA patients from small–medium metro areas had 17% higher mortality risk (aHR, 1.17; all P < 0.05).Conclusions:Among a population-based cohort of US adults with HCC, significant race/ethnicity-specific disparities across the HCC care continuum were observed. Lower household income and more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients.Impact:Our study shows that lower income and less urban/more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients with HCC. This contextualizes the complex relationship between sociodemographic factors and HCC outcomes through an intersectional lens.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Background:Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the United States.Methods:Using NCI registry data spanning 2000 to 2020, adults with HCC were evaluated to determine race/ethnicity-specific differences in tumor stage at diagnosis, delays and gaps in treatment, and survival. Adjusted regression models evaluated predictors of HCC outcomes.Results:Among 112,389 adults with HCC, cohort characteristics were as follows: 49.8% non-Hispanic White (NHW), 12.0% African American(AA), 20.5% Hispanic, 16.5% Asian/Pacific Islander, and 1.1% American Indian/Alaska Native. Compared with NHW patients, AA patients had lower odds of localized-stage HCC at diagnosis [adjusted odds ratio (aOR), 0.84], lower odds of HCC treatment receipt (aOR, 0.77), greater odds of treatment delays (aOR, 1.12), and significantly greater risk of death [adjusted hazards ratio (aHR), 1.10]. Compared with NHW patients from large metro areas, AA patients from large metro areas had 8% higher mortality risk (aHR, 1.08), whereas AA patients from small–medium metro areas had 17% higher mortality risk (aHR, 1.17; all P < 0.05).Conclusions:Among a population-based cohort of US adults with HCC, significant race/ethnicity-specific disparities across the HCC care continuum were observed. Lower household income and more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients.Impact:Our study shows that lower income and less urban/more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients with HCC. This contextualizes the complex relationship between sociodemographic factors and HCC outcomes through an intersectional lens.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 2 shows the results from the adjusted multivariable logistic regression analyses evaluating for predictors of receipt of HCC treatment, stratified by race/ethnicity.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 2 shows the results from the adjusted multivariable logistic regression analyses evaluating for predictors of receipt of HCC treatment, stratified by race/ethnicity.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1A-E from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary figure 1A shows the overall 5-year survival of patients with HCC stratified by age groups. Supplementary figure 1B shows the overall 5-year survival of patients with HCC stratified by sex. Supplementary figure 1C shows the overall 5-year survival of patients with HCC stratified by race/ethnicity. Supplementary figure 1D shows the overall 5-year survival of patients with HCC stratified by geography. Supplementary figure 1E shows the overall 5-year survival of patients with HCC stratified by annual household income.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1A-E from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary figure 1A shows the overall 5-year survival of patients with HCC stratified by age groups. Supplementary figure 1B shows the overall 5-year survival of patients with HCC stratified by sex. Supplementary figure 1C shows the overall 5-year survival of patients with HCC stratified by race/ethnicity. Supplementary figure 1D shows the overall 5-year survival of patients with HCC stratified by geography. Supplementary figure 1E shows the overall 5-year survival of patients with HCC stratified by annual household income.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 5 shows results from the adjusted multivariable Cox proportional hazards model evaluating for predictors of overall mortality, stratified by race/ethnicity
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 5 shows results from the adjusted multivariable Cox proportional hazards model evaluating for predictors of overall mortality, stratified by race/ethnicity
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 1 shows the results of adjusted multivariable logistic regression analyses evaluating for predictors of tumor stage at diagnosis among patients with HCC, stratified by race/ethnicity.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 1 shows the results of adjusted multivariable logistic regression analyses evaluating for predictors of tumor stage at diagnosis among patients with HCC, stratified by race/ethnicity.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 6 shows results from the adjusted multivariable competing risks analyses evaluating for predictors of hepatocellular carcinoma-specific mortality.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 6 shows results from the adjusted multivariable competing risks analyses evaluating for predictors of hepatocellular carcinoma-specific mortality.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 4 shows the results from the adjusted multivariable logistic regression analyses evaluating for predictors of delays in HCC treatment (≥3 months vs. <3 months), stratified by race/ethnicity.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Supplementary Table 4 shows the results from the adjusted multivariable logistic regression analyses evaluating for predictors of delays in HCC treatment (≥3 months vs. <3 months), stratified by race/ethnicity.
- 5 December 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (2) , 355-365
Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Background: Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the United States. Methods: Using NCI registry data spanning 2000 to 2020, adults with HCC were evaluated to determine race/ethnicity-specific differences in tumor stage at diagnosis, delays and gaps in treatment, and survival. Adjusted regression models evaluated predictors of HCC outcomes. Results: Among 112,389 adults with HCC, cohort characteristics were as follows: 49.8% non-Hispanic White (NHW), 12.0% African American(AA), 20.5% Hispanic, 16.5% Asian/Pacific Islander, and 1.1% American Indian/Alaska Native. Compared with NHW patients, AA patients had lower odds of localized-stage HCC at diagnosis [adjusted odds ratio (aOR), 0.84], lower odds of HCC treatment receipt (aOR, 0.77), greater odds of treatment delays (aOR, 1.12), and significantly greater risk of death [adjusted hazards ratio (aHR), 1.10]. Compared with NHW patients from large metro areas, AA patients from large metro areas had 8% higher mortality risk (aHR, 1.08), whereas AA patients from small–medium metro areas had 17% higher mortality risk (aHR, 1.17; all P < 0.05). Conclusions: Among a population-based cohort of US adults with HCC, significant race/ethnicity-specific disparities across the HCC care continuum were observed. Lower household income and more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients. Impact: Our study shows that lower income and less urban/more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients with HCC. This contextualizes the complex relationship between sociodemographic factors and HCC outcomes through an intersectional lens.
- 5 December 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (2) , 355-365
Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
Background: Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the United States. Methods: Using NCI registry data spanning 2000 to 2020, adults with HCC were evaluated to determine race/ethnicity-specific differences in tumor stage at diagnosis, delays and gaps in treatment, and survival. Adjusted regression models evaluated predictors of HCC outcomes. Results: Among 112,389 adults with HCC, cohort characteristics were as follows: 49.8% non-Hispanic White (NHW), 12.0% African American(AA), 20.5% Hispanic, 16.5% Asian/Pacific Islander, and 1.1% American Indian/Alaska Native. Compared with NHW patients, AA patients had lower odds of localized-stage HCC at diagnosis [adjusted odds ratio (aOR), 0.84], lower odds of HCC treatment receipt (aOR, 0.77), greater odds of treatment delays (aOR, 1.12), and significantly greater risk of death [adjusted hazards ratio (aHR), 1.10]. Compared with NHW patients from large metro areas, AA patients from large metro areas had 8% higher mortality risk (aHR, 1.08), whereas AA patients from small–medium metro areas had 17% higher mortality risk (aHR, 1.17; all P < 0.05). Conclusions: Among a population-based cohort of US adults with HCC, significant race/ethnicity-specific disparities across the HCC care continuum were observed. Lower household income and more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients. Impact: Our study shows that lower income and less urban/more rural geography among racial/ethnic minorities are also associated with disparities in HCC outcomes, particularly among AA patients with HCC. This contextualizes the complex relationship between sociodemographic factors and HCC outcomes through an intersectional lens.